Introduction
Recent advances in molecular biology, human genetics, immu notherapies as well as stem cell therapies resulted in a better understanding of the underlying pathologies in several dis eases. Early detection as well as specification of pathological conditions is crucial with respect to initiating new and some times very expensive therapies. Hand in hand with new thera peutic strategies better imaging modalities have to be develo ped in order to optimize therapy monitoring. Considering the emerging future potential of stem cell therapies, new, nonin vasive and sensitive imaging modalities have been developed [1, 2] . For experimental and clinical applications of stem cells cell labeling and tracking is interesting to evaluate cell distri bution and homing. Tracking of cells after transplantation may be performed for monitoring the delivery and fate of the graft.
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Summary
For experimental and clinical applications of stem cells cell labeling and tracking is interesting to evaluate cell distribution and homing. Tracking of cells after transplantation can be performed for monitoring the delivery and faith of the graft. Furthermore, imaging techniques are part of the evaluation of the functional effects of cellu lar therapy in the organism of the host. Therefore, systematic investigations on the development and clinical evaluation of imaging techniques and their possible biological impact on stem cells is an emerging topic of today's applied stem cell research. This article refers to different labeling techniques of stem cells highlighting their promises for clinical use and discussing their possible risks. 
Schlüsselwörter
Principles and Techniques of Cell Labeling
To detect cells by contrastenhanced US they can be labeled with microbubbles targeting e.g. specific receptors expressed on the surface of the target cells [6] .
The principle of PET is the detection of radioactive tracers. The cells can be directly labeled before transplantation e.g. by incubation with indium111oxine ( 111 In) [17, 18] or fluorine 18fluordeoxyglucose (FDG) [19] . Another interesting ap proach of cell labeling for PET or SPECT imaging is the en hanced uptake of systematically applied tracers into the donor cells after transplantation. Before transplantation, the cells are transfected with a reporter gene like the sodium iodide symporter which promotes the in vivo cellular uptake of tech netium 99m ( 99m Tc) or iodine 124 ( 124 I) [20] . The generation of images by MRI is based on the variable arrangement of protons induced by magnetization and their rearrangement (relaxation) after change of the magnetic field induced by the MRI scanner. Two relaxation time con stants T1 and T2 are utilized to generate tissue contrast [21] . Principally, there are two major ways to label cells for MRI: using paramagnetic substances or superparamagnetic sub stances. Paramagnetic substances such as gadolinium (Gd) re duce the T1 relaxation time producing a hyperintensive (posi tive = white) contrast [21] [22] [23] [24] [25] . However, the current protocols basing on paramagnetic labeling reagents seem to be inferior to superparamagnetic agents in terms of cytotoxicity and abili ty of generating images of strong contrast [21] . Superpara magnetic agents are mainly basing on iron (Fe). They reduce the T2 relaxation time leading to a strong hypointensive (neg ative = black) contrast [21] . Iron labeling is usually performed using superparamagnetic small particles of iron oxide (SPIO) or ultrasmall particles of iron oxide (USPIO) [26] [27] [28] . They differ mainly in their particle size (20-120 nm) and their coat ing ((carboxy)dextran). SPIO like Endorem ® (Guerbet, Paris, France) or Resovist ® (Schering AG, Berlin, Germany) are al ready approved for clinical purposes (liver imaging). Labeling of various cell entities like immune cells and hematopoietic and nonhematopoietic stem cells with superparamagnetic agents such as particles of iron oxide has been established previously [29] [30] [31] . So far, many Fe labeling protocols are based on passive Fe incorporation by endocytosis whilst in vitro incubation of the cells with the labeling agent [32] . How ever, the total iron load (TIL) of each cell declines by each cell division. As the TIL correlates with the imaging quality [33] , transfection agents (TA) are applied being helpful with respect of transporting Fe into the target cell. Currently used TA are lipofectamine [34] , polyLlysine [35] , protamine sul phate [36] and polethylenimine (PEI) [37] . The positively charged TA, coating the negatively charged SPIO, leads to an enhanced SPIOcell binding via electrostatic interactions and finally to an enhanced uptake into the cell [29] . Interestingly, although significantly enhancing the TIL, complexes of TA and SPIO may remain for a certain time on the cellular sur Furthermore, imaging techniques are part of the evaluation of the functional effects of cellular therapy in the organism of the host. Noninvasive visualization of the biological properties of the donor cells after transplantation, e.g. with respect to sur vival, proliferation and differentiation, as well as visualization of the interactions of the graft with the host tissue are a goal of modern molecular medicine [3, 4] . Meanwhile, the first pa tients have been treated with labeled cells in clinical trials [5] . However, the book of knowledge about these methods is not yet finished. Therefore, systematic investigations on the develop ment and clinical evaluation of imaging techniques and their possible biological impact on stem cells are emerging topics of today's applied stem cell research.
Principles and Techniques of Cell Imaging
Cell imaging strategies include ultrasound (US) [6] , positron emission tomography (PET) imaging [7] , single photon emis sion computer tomography (SPECT) [8] , optical imaging (OI) [9] , and magnetic resonance imaging (MRI) [10] [11] [12] , all of them with strengths and weaknesses.
US is a cheap method which can be performed without sumptuous preparations; however, the spatial resolution is limited and the detection of the specific signal could be hin dered, e.g. by gascontaining compartments like the gastroin testinal system.
Although providing excellent sensitivity, limitations of PET imaging are its limited spatial resolution [13] and the relatively short halflife time of several tracers (e.g. F18 T 1/2 = 110 min); thus PET imaging would be possible only within a short period after cell application.
Another very sensitive modality is OI, which can be helpful especially in small animal models [14] . However, OI is of limi ted value when imaging humans due to its poor tissue pene tration (only a few centimeters when using fluorochromes at a wavelength of 700-800 nm). An additional problem is the quantification of the signal.
MRI at higher field strength (≥1.5 Tesla) could be a good compromise when using special amplification methods as well as dedicated sequences and coils. Compared to PET and OI, the sensitivity of MRI is lower by the factor 10 2 -10 5 , depend ing on the structures examined. On the other hand, MRI of fers a superb spatial resolution (300 mm can be easily achieved compared to 5-10 mm using PET). Other advantages of MRI are the lack of radiation exposure, and object/patient size ('being to large') is not a limiting issue. Additionally, repeti tive examinations over a longer time period (up to 6 weeks) have already been performed successfully [15] . Due to its high resolution and excellent tissue contrast, MRI has been most widely applied to track stem cells after transplantation [16] . It is assumed that more reporter gene based technologies for 'smart imaging' of distinct properties of transplanted stem cells will be developed in the near future.
Concerns about Cell Labeling
Every technique has its limitations and possible undesired ef fects, and this is also the case for cell labeling. Little is known about the use of ionizing radiation by PET tracers with re spect to possible effects on the DNA. The high voltage treat ment of the cells using magnetoelectroporation may nega tively affect cell types with functionally important electro physiological properties like neural stem cells (NSCs), neuro nal cells or cardiomyocytes, or generally affect the viability of sensitive cells. Reporter gene techniques appear to have a bright and promising future. However, what do we know today about longterm effects of genetic engineering, even if transgene silencing is a major goal?
Referring to the 'simple' Fe labeling techniques using even clinically established SPIO, emerging reports highlight unde sired effects of cell labeling. Despite the initial assumption that internalized SPIO may be metabolically 'inert', there is evidence that the Fe particles interact with the cell's iron me tabolism [33, 51] . Currently it is unclear which longterm ef fects this interaction may have. Referring to functional effects of labeling on stem cells, SPIO labeling with TA of rat MSCs led to an increase in disease severity in a rat model of multiple sclerosis [52] . Moreover, labeling of human MSCs with SPIO in combination with TA led to a decrease of migration capa city in vitro, and labeling of human MSCs with SPIO with and without TA led to a significant decrease of ability of colony formation [37] . Kostura et al. [53] reported on the inhibition of chondrogenic differentiation capacity of human MSCs by SPIO labeling. Another study reported on the shift of (U) SPIO labeled macrophages toward an antiinflammatory, less responsive phenotype and the influence of macrophage label ing on the T cellmacrophage interaction [54] . But also TA like polyLlysine or PEI may cause serious side effects such as fibrosis or cytotoxicity [55, 56] .
Clinical Studies
In 2003 de Vries et al. [57] tracked successfully the migration of dendritic cells (DCs) to lymph nodes in melanoma patients by in vivo imaging of 111 In labeled DCs by scintigraphy. To date there are reports on four completed clinical studies on MRI imaging of labeled cells in humans.
In the first MRI study again melanoma patients were en rolled: They received autologous DCs labeled with SPIO with out TA or 111 In labeled DCs injected into the lymph nodes. In contrast to scintigraphic imaging, MRI allowed assessment of the accuracy of DC delivery and of inter and intranodal cell face before being taken up [37] . If this phenomenon may have an impact e.g. on extracellularly expressed receptors and the interaction with their ligands remain to be elucidated. More over, with respect to the principles of good manufacturing practice (GMP), a prolonged in vitro incubation time with all its risks of cell culture may not be desirable. Therefore, ad vanced techniques have been developed in order to deliver the labeling agent as quick as possible into the cell. Exposing the cells to an electrical pulse (130 V) provokes a temporal increase of the permeability of the cell membrane, leading to an enhanced uptake of the labeling agent into the cell. This method called magnetoelectroporation is effective in terms of labeling of many cells in a very short time [38, 39] . Magne tosonoporation can also increase the permeability of the cell membrane in order to enhance the uptake of the labeling agent. Exposure to low frequency US (1-3 MHz) can create temporary pores into the cell membrane of up to 100 nm by the acoustic cavitation effect [40, 41] . Liu et al. [42] effectively labeled human mesenchymal stem cells (MSCs) with SPIO by microbubble enhanced US exposure, referring to previous re ports that US exposure in the presence of microbubbles can increase the transfection efficiency [43, 44] . An alternative ap proach combining stem cell labeling for MRI with specific positive selection techniques is the use of magnetic beads linked to specific antibodies such as antiCD34 [45] or specific aptamers [46] .
Referring to the sensitivity, using clinical MRI scanners 5,000 SPIO+TA labeled stem cells could be detected in vitro [33] , and the sensitivity of Fe labeling of cells in vivo allowed even single cell detection by MRI in small animal models [47, 48] .
Even if 'simple' Fe labeling appears attractive and potent, one major limitation is that the detected signal refers only to the applied Fe particles and gives no information about the viability and the biological status (differentiation, metabolic or mitotic activity) of the cell labeled prior to the transplanta tion. Moreover, the signal may be generated from Fe particles which were detached from the labeled donor cells and/or in gested into host cells. In order to overcome these problems of direct cell labeling, reporter gene methods were also devel oped for cell imaging by MRI.
Introducing a metalloprotein from the ferritin family as a reporter gene, the transduced cells sequestered endogenous (superparamagnetic) Fe from the organism [49] . No exoge nous metal complexed contrast agent was required, thereby simplifying intracellular delivery. Following focal inoculation of the vector into the mouse brain, the reporter activity was monitored using in vivo MRI.
Gilad et al. [50] designed a nonmetallic, biodegradable, lysine rich protein reporter, expressing an artificial protein with frequency selective contrast. This endogenous contrast produced only by transfected viable cells is based on transfer of radiofrequency labeling from the reporter's amide protons to water protons. 
Conclusion
Labeling and imaging of (stem) cells is feasible, and imaging by MRI seems to be the most promising approach for possible clinical applications. Certainly, new therapeutic strategies, e.g. in the emerging field of regenerative medicine, imply a need of knowledge about the homing and survival of the cellular graft. Here, basic research was brilliantly performed in animal models [8, 10, 15, 29, 62] . Moreover, there is a realistic chance that we could gain new insights of stem cell function and dis eases using advanced cell labeling techniques. However, re ferring to the concerns, the basic principle for all medical treatments and diagnostics may always be 'nihil nocere'. As hematopoietic stem cell transplantation has been performed successfully for decades, no urgent need was and maybe is for individual imaging of the cellular graft in each patient. There fore, the goals and risks of cell labeling and imaging may be considered when proceeding on introducing advanced label ing techniques into the clinic.
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The author declared no conflict of interest. migration patterns. In this study, the detection limit by MRI was calculated of about 15,000 SPIO labeled DCs. Impor tantly, a clinically highly valuable result was that the in vivo MRI revealed a high misinjection rate of about 50% -a find ing that would not be generated without the use of MRI [58] .
A case report of a patient with traumatic brain injury re ceiving autologous NSCs marks the second clinical applica tion and imaging of Fe labeled cells: The NSCs were labeled with SPIO in combination with TA and injected stereotacti cally into the brain. MRI showed a migration of the NSCs to ward the site of the injury [59] . Another group performed suc cessfully MRI imaging of bone marrow derived CD34+ cells in patients with chronic spinal cord injury. The cells were la beled with large magnetic 'macrobeads' (mean diameter about 4 mm) linked to antiCD34 antibodies and were applied into the spinal cord [60] . Finally, a Swiss study reported on a clinical investigation of diabetic patients receiving intrapor tally SPIO labeled islets [61] . The signal could be detected by MRI in a longterm followup for 6 months, and no functional affection of the cellular graft with respect to insulin produc tion could be observed.
